Royalty Pharma (RPRX) P/E (2020 - 2026)
Royalty Pharma (RPRX) P/E from Jun 30, 2020 to Jul 21, 2026. The TTM Royalty Pharma (RPRX) P/E is 29.76. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Royalty Pharma (RPRX)
| Year | P/E | Change |
|---|---|---|
| 2026 | 29.76 | +92.83% |
| 2025 | 15.43 | -2.42% |
| 2024 | 15.82 | -1.15% |
| 2023 | 16.00 | -44.13% |
| 2022 | 28.64 | +63.69% |
| 2021 | 17.50 | -28.88% |
| 2020 | 24.60 | N/A |
Comparison Royalty Pharma (RPRX) P/E with competitors
Royalty Pharma (RPRX) P/E is 29.76.